These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32251655)

  • 1. Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation.
    Barac YD; Mulvihill MS; Jawitz O; Klapper J; Haney J; Daneshmand M; Nasir B; Chen D; Milano CA; Hartwig MG
    Ann Thorac Surg; 2020 Aug; 110(2):414-423. PubMed ID: 32251655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list.
    Kransdorf EP; Kittleson MM; Patel JK; Pando MJ; Steidley DE; Kobashigawa JA
    J Heart Lung Transplant; 2017 Jul; 36(7):787-796. PubMed ID: 28318744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.
    Tague LK; Witt CA; Byers DE; Yusen RD; Aguilar PR; Kulkarni HS; Bain KB; Fester KA; Puri V; Kreisel D; Mohanakumar T; Trulock EP; Hachem RR
    Ann Am Thorac Soc; 2019 Jul; 16(7):846-852. PubMed ID: 30763122
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates.
    Aversa M; Benvenuto L; Kim H; Shah L; Robbins H; Stanifer BP; D'Ovidio F; Vasilescu ER; Sonett J; Arcasoy SM
    Ann Transplant; 2019 Jun; 24():383-392. PubMed ID: 31249284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of organ prioritization for immunologic sensitization and waiting times for heart transplantation.
    Aleksova N; Alba AC; Fan CS; Mueller B; Mielniczuk LM; Davies RA; Stadnick E; Ross HJ; Chih S
    J Heart Lung Transplant; 2019 Mar; 38(3):285-294. PubMed ID: 30658880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
    Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation.
    Gragert L; Kadatz M; Alcorn J; Stewart D; Chang D; Gill J; Liwski R; Gebel HM; Gill J; Lan JH
    Am J Transplant; 2022 Dec; 22(12):3093-3100. PubMed ID: 35975734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between calculated panel reactive antibody and waitlist outcomes in the 2018 heart allocation system.
    DeFilippis EM; Ji Z; Masotti M; Maharaj V; Alexy T; Kittleson MM; Cogswell R
    J Heart Lung Transplant; 2023 Oct; 42(10):1469-1477. PubMed ID: 37268050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of blood group on lung transplantation rates: A propensity-matched registry analysis.
    Barac YD; Mulvihill MS; Cox ML; Bishawi M; Klapper J; Haney J; Daneshmand M; Hartwig MG
    J Heart Lung Transplant; 2019 Jan; 38(1):73-82. PubMed ID: 30366846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in donor organ offer acceptance and lung transplantation survival.
    Mulvihill MS; Lee HJ; Weber J; Choi AY; Cox ML; Yerokun BA; Bishawi MA; Klapper J; Kuchibhatla M; Hartwig MG
    J Heart Lung Transplant; 2020 Apr; 39(4):353-362. PubMed ID: 32029400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does lung allocation score maximize survival benefit from lung transplantation?
    Russo MJ; Worku B; Iribarne A; Hong KN; Yang JA; Vigneswaran W; Sonett JR
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1270-7. PubMed ID: 21497235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculated panel reactive antibody with decimals: A refined metric of access to transplantation for highly sensitized candidates.
    Kransdorf EP; Pando MJ
    Hum Immunol; 2017 Mar; 78(3):252-256. PubMed ID: 28069404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell donor HLA typing improves CPRA in kidney allocation.
    Kransdorf EP; Pando MJ; Stewart D; Lindblad K; Bray R; Murphey C; Kaur N; Patel JK; Kim I; Zhang X; Maiers M; Kobashigawa JA; Gragert L
    Am J Transplant; 2021 Jan; 21(1):138-147. PubMed ID: 32558252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parsing the 100% calculated panel reactive antibody kidney transplant candidates: Who gets transplanted?
    Keith DS
    HLA; 2020 Jan; 95(1):23-29. PubMed ID: 31515960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified method of calculating cPRA for kidney allocation application in Hong Kong: a retrospective study.
    Chan YP; Wong MWK; Tang LWM; Guo M; Yang W; Ip P; Li PKT; Leung CB; Chau KF; Lam JCK; Yeung NKM; Kwok JSY
    Transpl Int; 2017 Dec; 30(12):1234-1242. PubMed ID: 28777478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The real unmet need: A multifactorial approach for identifying sensitized kidney candidates with low access to transplant.
    Maldonado AQ; Bradbrook K; Sjöholm K; Kjellman C; Lee J; Stewart D
    Clin Transplant; 2023 May; 37(5):e14946. PubMed ID: 36841966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Advantage of Multiple Listing Continues in the Kidney Allocation System Era.
    Decoteau MA; Stewart DE; Toll AE; Kurian SM; Case J; Marsh CL
    Transplant Proc; 2021 Mar; 53(2):569-580. PubMed ID: 33549345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients.
    Baxter-Lowe LA; Kucheryavaya A; Tyan D; Reinsmoen N
    Hum Immunol; 2016 May; 77(5):395-402. PubMed ID: 27012168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system.
    Houp JA; Schillinger KP; Eckstein AJ; Vega RM; Desai NM; Lonze BE; Jackson AM
    Hum Immunol; 2017 Jan; 78(1):49-53. PubMed ID: 27890719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia.
    Sypek MP; Kausman JY; Watson N; Wyburn K; Holt SG; Hughes P; Clayton PA
    Transplantation; 2021 Jun; 105(6):1317-1325. PubMed ID: 34019363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.